Research progress on biomarkers and detection methods for Alzheimer's disease diagnosis in vitro.
10.3760/cma.j.cn112150-20230517-00385
- Author:
Yu Ting ZHANG
1
;
Ze ZHANG
1
;
Ying Cong ZHANG
1
;
Xin XU
1
;
Zhang Min WANG
1
;
Tong SHEN
1
;
Xiao Hui AN
1
;
Dong CHANG
1
Author Information
1. Department of Laboratory Medicine, Fudan University Affiliated Pudong Medical Center, Shanghai 201399, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Alzheimer Disease/diagnosis*;
Neurodegenerative Diseases;
Early Diagnosis;
Cognitive Dysfunction;
Biomarkers
- From:
Chinese Journal of Preventive Medicine
2023;57(11):1888-1894
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset, posing a serious threat to human physical and mental health. The cognitive impairments caused by AD are generally diffuse and overlap symptomatically with other neurodegenerative diseases. Moreover, the symptoms of AD are often covert, leading to missed opportunities for optimal treatment after diagnosis. Therefore, early diagnosis of AD is crucial. In vitro diagnostic biomarkers not only contribute to the early clinical diagnosis of AD but also aid in further understanding the disease's pathogenesis, predicting disease progression, and observing the effects of novel candidate therapeutic drugs in clinical trials. Currently, although there are numerous biomarkers associated with AD diagnosis, the complex nature of AD pathogenesis, limitations of individual biomarkers, and constraints of clinical detection methods have hindered the development of efficient, cost-effective, and convenient diagnostic methods and standards. This article provides an overview of the research progress on in vitro diagnostic biomarkers and detection methods related to AD in recent years.
